| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.2M | +11.8% |
| Cost of Revenue | $1.1M | +10.6% |
| Gross Profit | $2.1M | +12.5% |
| R&D Expense | $275K | -90.4% |
| SG&A Expense | $39.2M | -12.3% |
| Operating Income | -$113.6M | +35.8% |
| Interest Expense | $2.8M | -3.6% |
| Income Tax | $12K | -62.5% |
| Net Income | -$105.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $173.3M | +322.9% |
| Accounts Receivable | $526K | -31.0% |
| Current Assets | $180.2M | +160.1% |
| Total Assets | $483.3M | +28.9% |
| Current Liabilities | $53.9M | +61.2% |
| Total Liabilities | $59.7M | -36.8% |
| Stockholders' Equity | $416.1M | +54.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$89.2M | +45.0% |
| Capital Expenditures | $1.2M | -58.9% |
| Investing Cash Flow | $4.6M | +131.7% |
| Financing Cash Flow | $214.7M | +1036.4% |
| Free Cash Flow | -$90.4M | +45.2% |
| +17.7% |
| EPS (Basic) | $0.79 | -26.2% |
| EPS (Diluted) | $0.79 | -26.2% |